Electromed Net Income
| ELMD Stock | USD 24.26 0.95 4.08% |
As of the 14th of February 2026, Electromed shows the Coefficient Of Variation of 7402.79, downside deviation of 3.33, and Mean Deviation of 2.1. Electromed technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Electromed coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Electromed is priced favorably, providing market reflects its regular price of 24.26 per share. Given that Electromed has jensen alpha of (0), we urge you to verify Electromed's prevailing market performance to make sure the company can sustain itself at a future point.
Electromed Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.7152 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 3.6 M | 3.8 M | |
| Net Income | 8.7 M | 9.1 M | |
| Net Income From Continuing Ops | 8.7 M | 9.1 M | |
| Net Income Per Share | 0.81 | 0.85 | |
| Net Income Per E B T | 0.66 | 0.48 |
Electromed | Net Income | Build AI portfolio with Electromed Stock |
Analyzing Electromed's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Electromed's current valuation and future prospects.
Latest Electromed's Net Income Growth Pattern
Below is the plot of the Net Income of Electromed over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Electromed financial statement analysis. It represents the amount of money remaining after all of Electromed operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Electromed's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Electromed's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 7.54 M | 10 Years Trend |
|
Net Income |
| Timeline |
Electromed Net Income Regression Statistics
| Arithmetic Mean | 2,919,531 | |
| Geometric Mean | 2,125,019 | |
| Coefficient Of Variation | 107.12 | |
| Mean Deviation | 2,384,152 | |
| Median | 2,229,472 | |
| Standard Deviation | 3,127,275 | |
| Sample Variance | 9.8T | |
| Range | 10.4M | |
| R-Value | 0.90 | |
| Mean Square Error | 2T | |
| R-Squared | 0.80 | |
| Slope | 555,363 | |
| Total Sum of Squares | 156.5T |
Electromed Net Income History
Other Fundumenentals of Electromed
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Electromed Net Income component correlations
Electromed Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Electromed is extremely important. It helps to project a fair market value of Electromed Stock properly, considering its historical fundamentals such as Net Income. Since Electromed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Electromed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Electromed's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Electromed diversify its offerings? Factors like these will boost the valuation of Electromed. Projected growth potential of Electromed fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Electromed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.455 | Earnings Share 1.03 | Revenue Per Share | Quarterly Revenue Growth 0.163 | Return On Assets |
Electromed's market price often diverges from its book value, the accounting figure shown on Electromed's balance sheet. Smart investors calculate Electromed's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Electromed's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Electromed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Electromed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Electromed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Electromed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Electromed.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Electromed on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Electromed or generate 0.0% return on investment in Electromed over 90 days. Electromed is related to or competes with Perspective Therapeutics, Helius Medical, Nano X, Inogen, Profound Medical, TriSalus Life, and Outset Medical. Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply hig... More
Electromed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Electromed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Electromed upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.33 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 15.02 | |||
| Value At Risk | (5.15) | |||
| Potential Upside | 4.08 |
Electromed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Electromed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Electromed's standard deviation. In reality, there are many statistical measures that can use Electromed historical prices to predict the future Electromed's volatility.| Risk Adjusted Performance | 0.0181 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0551 |
Electromed February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0181 | |||
| Market Risk Adjusted Performance | 0.0651 | |||
| Mean Deviation | 2.1 | |||
| Semi Deviation | 3.21 | |||
| Downside Deviation | 3.33 | |||
| Coefficient Of Variation | 7402.79 | |||
| Standard Deviation | 2.87 | |||
| Variance | 8.21 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0551 | |||
| Maximum Drawdown | 15.02 | |||
| Value At Risk | (5.15) | |||
| Potential Upside | 4.08 | |||
| Downside Variance | 11.08 | |||
| Semi Variance | 10.33 | |||
| Expected Short fall | (2.02) | |||
| Skewness | (0.96) | |||
| Kurtosis | 1.83 |
Electromed Backtested Returns
At this point, Electromed is very steady. Electromed secures Sharpe Ratio (or Efficiency) of close to zero, which denotes the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Electromed, which you can use to evaluate the volatility of the firm. Please confirm Electromed's Mean Deviation of 2.1, coefficient of variation of 7402.79, and Downside Deviation of 3.33 to check if the risk estimate we provide is consistent with the expected return of 0.0157%. The firm shows a Beta (market volatility) of 0.52, which means possible diversification benefits within a given portfolio. As returns on the market increase, Electromed's returns are expected to increase less than the market. However, during the bear market, the loss of holding Electromed is expected to be smaller as well. Electromed right now shows a risk of 2.84%. Please confirm Electromed maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if Electromed will be following its price patterns.
Auto-correlation | -0.03 |
Very weak reverse predictability
Electromed has very weak reverse predictability. Overlapping area represents the amount of predictability between Electromed time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Electromed price movement. The serial correlation of -0.03 indicates that only 3.0% of current Electromed price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 2.22 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Electromed Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Electromed reported net income of 7.54 M. This is 97.79% lower than that of the Health Care Equipment & Supplies sector and 96.83% lower than that of the Health Care industry. The net income for all United States stocks is 98.68% higher than that of the company.
Electromed Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Electromed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Electromed could also be used in its relative valuation, which is a method of valuing Electromed by comparing valuation metrics of similar companies.Electromed is currently under evaluation in net income category among its peers.
Electromed Current Valuation Drivers
We derive many important indicators used in calculating different scores of Electromed from analyzing Electromed's financial statements. These drivers represent accounts that assess Electromed's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Electromed's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 81.7M | 90.6M | 121.2M | 183.3M | 165.0M | 173.2M | |
| Enterprise Value | 73.6M | 83.4M | 105.2M | 168.2M | 151.4M | 158.9M |
Electromed ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Electromed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Electromed's managers, analysts, and investors.Environmental | Governance | Social |
Electromed Fundamentals
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 186.97 M | ||||
| Shares Outstanding | 8.28 M | ||||
| Shares Owned By Insiders | 21.45 % | ||||
| Shares Owned By Institutions | 54.64 % | ||||
| Number Of Shares Shorted | 173.79 K | ||||
| Price To Earning | 23.66 X | ||||
| Price To Book | 4.42 X | ||||
| Price To Sales | 2.94 X | ||||
| Revenue | 64 M | ||||
| Gross Profit | 53.87 M | ||||
| EBITDA | 10.83 M | ||||
| Net Income | 7.54 M | ||||
| Cash And Equivalents | 8.15 M | ||||
| Cash Per Share | 0.96 X | ||||
| Total Debt | 198 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 4.83 X | ||||
| Book Value Per Share | 5.49 X | ||||
| Cash Flow From Operations | 11.39 M | ||||
| Short Ratio | 3.56 X | ||||
| Earnings Per Share | 1.03 X | ||||
| Target Price | 36.67 | ||||
| Number Of Employees | 177 | ||||
| Beta | 0.26 | ||||
| Market Capitalization | 202.34 M | ||||
| Total Asset | 53.8 M | ||||
| Retained Earnings | 21.18 M | ||||
| Working Capital | 34.61 M | ||||
| Current Asset | 15.82 M | ||||
| Current Liabilities | 3.07 M | ||||
| Net Asset | 53.8 M |
About Electromed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Electromed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:Check out For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Will Health Care Equipment & Supplies sector continue expanding? Could Electromed diversify its offerings? Factors like these will boost the valuation of Electromed. Projected growth potential of Electromed fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Electromed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.455 | Earnings Share 1.03 | Revenue Per Share | Quarterly Revenue Growth 0.163 | Return On Assets |
Electromed's market price often diverges from its book value, the accounting figure shown on Electromed's balance sheet. Smart investors calculate Electromed's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Electromed's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Electromed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Electromed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.